The following posters will be presented at the Symposium.  Abstracts of the talks and posters have been posted here beginning November 15, 2009.

POSTER SESSION 1 (MONDAY, NOVEMBER 16)

POSTER 1, Jaideep Karamchandani
Identification of Residues within the L-SIGN Carbohydrate Recognition
Domain (CRD) That Interact with West Nile Virus (Abstract)

POSTER 2, Benjamin Luttge
FIV Env Mutations Enhance Cell-Cell Transmission to Escape
TSG-5'-Mediated Inhibition of Both FIV Release and Cell-Free FIV Infection (Abstract)

POSTER 3, Kamlendra Singh
Kinetics of Nucleic Acid Unwinding and Nucleotide Hydrolysis by
SARS-CoV Helicase (Abstract)

POSTER 4, B. Christie Vu
4'C-substituted-2-deoxyadenosine Is a Delayed Chain Terminator of
HIV-1 Reverse Transcriptase (Abstract)

POSTER 5, HimaBindu Chunduri
Increased Processivity of HIV-1 Reverse Transcriptase Containing a
Leu74—>Ile Change in the Background of Lys65Arg Leads to a
Replication-Competent Virus (Abstract)

POSTER 6, Matthew Schuckmann
Biochemical Characterization of the HIV Reverse Transcriptase
Connection Domain Multi-Class Drug Resistance Mutation N348I (Abstract)

POSTER 7, Stefan Sarafianos
The NNRTI-Resistant Y181C HIV-1 Reverse Transcriptase Is
Hyper-Susceptible to 4'-Ethynyl-2-Fluoro Deoxyadenosine (EFdA) (Abstract)

POSTER 8, Atsuko Hachiya
K70Q Expands Multi-Drug Resistance (MDR) of HIV-1 Containing
"Q151M Complex" Reverse Transcriptase Mutations (Abstract)

POSTER 9, Sean Rigby
Invasion-Mediated Strand Transfer during HIV-1 Reverse Transcription
Must Be Completed over Short Distances and Requires Various
Modes of RNase H Cleavage by RT (Abstract)

POSTER 10, Sarah Van Cor-Hosmer
Mechanistic Interplay between Central Polypurine Tract Sequence
and the Reverse Transcriptase Inhibitor Sensitivity of Human
Immunodeficiency Virus Type 1 (Abstract)

POSTER 11, Wen Shen
Runs of Guanosine Residues in Gag Hot Spot for Recombination in
HIV-1 Form G-Quartet and Promote Strand Transfer in Vitro (Abstract)

POSTER 12, Johnson Mak
Consideration of Multiple Template Switches Is Critical to the
Determination of the Recombination Rate on the HIV Genome (Abstract)

POSTER 13, Andrea Lisco
Acyclovir Inhibits HIV-1 Reverse Transcriptase and Selects Resistant
Variants in Vitro (Abstract)

POSTER 14, Egor Tchesnokov
The Mechanism of Action of Ganciclovir Depends on the Nature of the
Targeted Viral Polymerase (Abstract)

POSTER 15, Rieko Ishima
Structural Characterization of the Interaction of the RT RNase H Inhibitor (Abstract)

POSTER 16, Tatiana Ilina
Novel RNA/DNA Substrates for the Characterization of Ribonuclease H
Activity (Abstract)

POSTER 17, Michal Legiewicz
aiSHAPE Resolves Architecture of Tertiary Interactions within the
RNA Export Element of Murine LTR Retrotransposon (Abstract)

POSTER 18, Yi Wang
Direct Probing of RNA Transport Element Structures by SHAPE,
Solution X-ray Scattering and 3D Mass Spectrometry (Abstract)

POSTER 19, Katarzyna Purzycka
HIV-2 Leader RNA: Structure Probing and Complex Formation with
Recombinant HIV-2 Nucleocapsid Protein NCp8 (Abstract)

POSTER 20, Ivana Massud
Characterization of HIV-2 Q151M Mutation (Abstract)

POSTER 21, Yuao Zhu
HBV DNA Replication Mediated by Cloned Patient RT Genes from
HBV Genotypes A-H and Its Use in Antiviral Phenotypic Assays (Abstract)

POSTER 22, Megan Powdrill
Characterization of Nucleotide Binding during the Elongation Phase
of Hepatitis C RNA Synthesis (Abstract)

POSTER 23, Mia Biondi
N348I in HIV-1 Reverse Transcriptase Can Counteract the Nevirapine
Mediated Bias toward RNase H Cleavage during Plus-Strand Initiation (Abstract)

POSTER 24, Ting Nie
Universal Protocol for Sequencing HIV-1 pol across Clades for Subtype
Identification and Analysis of Drug Resistance (Abstract)

POSTER 25, Margaret Lange
Engineering Aptamers to HIV-1 RT for Improved Antiviral Bioactivity (Abstract)

POSTER 26, Donald Burke
Secondary Structures for an Expanded Set of RNA Aptamers
Targeted to HIV-1 Reverse Transcriptase (Abstract)

POSTER 27, Jean Bernatchez
Derivatives of Mesoxalic Acid Inhibit Translocation of HIV-1 Reverse
Transcriptase (Abstract)

POSTER 28, Suhman Chung
Syntheses and Evaluations of Manicol Derivatives as Inhibitors of HIV-1
RNase H Activity (Abstract)

POSTER 29, Lauren Beach
Anti-HIV Activity and Evolutionary Conservation of Trim 37 (Abstract)

POSTER 30, Vladimir Pak
Mutational Analysis of the Determinants for Cytoplasmic Localization
and Anti-Retroviral Activity of APOBEC3B (Abstract)

POSTER 31, Silvia Sanchez-Martinez
Understanding the Mechanism of MLV's Resistance to Mouse Apobec3:
Mouse Apobec3 Purification from Sf9 Insect Cells (Abstract)

POSTER 32, Ming Li
Preliminary Characterization of APOBEC3G DNA Deaminase Inhibitors
Identified by High Throughput Screening (Abstract)

POSTER 33, Wei Bu
APOBEC3F Blocks HIV-1 Integration by Inhibiting Viral 3' End Processing (Abstract)

POSTER 34, Christopher McKee
Examining HIV-1 Integrase Interactions with vDNA and LEDGF Defines
the Sequence of Events for Productive Concerted Integration (Abstract)

POSTER 35, Jocelyn Eidahl
Mass Spectrometry-Based Footprinting of LEDGF Interactions with
Chromatinized Templates (Abstract)

POSTER 36, Talapady Bhat
A Ligand Facebook for AIDS and Beyond (Abstract)

POSTER SESSION 2 (TUESDAY, NOVEMBER 17)

POSTER 37, Claudia Sepúlveda
Inhibition of Arenavirus Infection by Thiuram and Aromatic Disulfides (Abstract)

POSTER 38, Jay Thakkar
Low Molecular Weight Lignins as Potent Inhibitors of Viral Entry into
Mammalian Cells (Abstract)

POSTER 39, Lori Emert-Sedlak
Chemical Library Screens Targeting an HIV-1 Nef/Host Cell Kinase
Complex Identify Novel Anti-Retroviral Compounds (Abstract)

POSTER 40, Serge Benichou
Llama Single-Domain Antibody Fragment for Inhibition of the HIV-1
Nef Protein (Abstract)

POSTER 41, Ji Chang You
The Development of Novel Types of Anti-HIV Inhibitors against the
HIV Nucleocapsid Protein (Abstract)

POSTER 42, Dan Andersson
New Mechanism of HIV Resistance: Investigating Cleavage Site
Mutations in Gag (Abstract)

POSTER 43, Bertram Canagarajah
Crystal Structure of the Tsg101 UEV Domain in Complex with the
PTAP Motif of the HIV-1 Gag Protein (Abstract)

POSTER 44, Michael Kinch
TSG101 Antibody Targeting: Opportunities for Broad-Spectrum
Targeting of Multiple Drug-Resistant Virus Types (Abstract)

POSTER 45, Abdul Waheed
Studies on Vpu-Mediated Antagonism of the Host Restriction Factor
CD317 (Tetherin) (Abstract)

POSTER 46, Olga Nikolaitchik
Probing the HIV-1 Genomic RNA Trafficking Pathway and Dimerization
by Genetic Recombination and Single Virion Analyses (Abstract)

POSTER 47, Tania Lombo
Packaging of Cellular RNAs in Retrovirus Particles: asb-1 (Abstract)

POSTER 48, Mary Ann Checkley
The Capsid-Spacer Peptide 1 Gag Processing Intermediate Is a
Dominant-Negative Inhibitor of HIV-1 Maturation (Abstract)

POSTER 49, Kevin Whitby
A Small Molecule Inhibitor of HIV-1 Infection Has a Cyclophilin-
Dependent Mechanism and Acts by Destabilising the Viral Capsid (Abstract)

POSTER 50, Liangqun Huang
Modulation of HIV-1 Protease Autoprocessing by Charge Properties
of Surface Residue 69 under Different Contexts (Abstract)

POSTER 51, Takashi Masaoka
Development of Method for Testing HIV-1 Protease Drug-Resistance
Based on Cell-Free Protein Production System (Abstract)

POSTER 52, Richard Barnard
Longitudinal Clonal Resistance Analysis of Treatment-Naïve Patients
with Chronic Hepatitis C (CHC) Genotype 1 Infection Treated with MK-7009,
a Novel NS3/4A Protease Inhibitor, in Combination with Pegylated
Interferon Alpha-2a and Ribavirin for 28 Days (Abstract)

POSTER 53, Junko Shibata
Within-Host Coevolution of Gag P453L and Protease D30N/N88D
Demonstrates Virological Advantage in a Highly Protease Inhibitor-
Exposed HIV-1 Case (Abstract)

POSTER 54, Jennifer Giandhari
Characterisation of Protease Cleavage Sites in Protease Inhibitor-Naïve
Patients Infected with HIV-1 Subtype C (Abstract)

POSTER 55, Sung-Geun Lee
The Molecular Epidemiology and Antibody Production for Norovirus (Abstract)

POSTER 56, Chang-Il Suh
Screening of HIV PMPA Resistant Strain and Medicinal Plant Extract
for Anti-HIV-1 Activity (Abstract)

POSTER 57, Dara Lehman
Lower Risk of Resistance Following Short-Course HAART Compared
to Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1
Mother-to-Child Transmission (Abstract)

POSTER 58, Keikantse Matlhagela
Major Variant Mutations as Predictors of Antiretroviral Treatment
Failure in Mothers Exposed to Single-Dosed Nevirapine (Abstract)

POSTER 59, Sinaye Ngcapu
Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Associated
Mutations in the RNase H Region in South African Adults and
Children Failing Highly Active Antiretroviral Therapy (HAART) (Abstract)

POSTER 60, Taryn Green
Prevalence of Drug Resistance in HIV-1 Subtype C-Infected Children
Failing Antiretroviral Therapy in South Africa (Abstract)

POSTER 61, Frank Maldarelli
Raltegravir Intensification Does Not Reduce Persistent HIV-1 Viremia
in Treatment Experienced Patients (Abstract)

POSTER 62, Carrie Poethke
Antiretroviral Drug Adherence in a Standard of Care HIV Clinic (Abstract)

POSTER 63, Angela Mexas
CXCR4-Tropic Human Immunodeficiency Virus Can Establish Latent
Infection in Naïve CD4+ Resting T Cells (Abstract)

POSTER 64, Erin Graf
A Sensitive and Precise Assay for Integrated HIV DNA Can Be
Used to Measure Viral Reservoir Size in HIV-Positive Elite Suppressors (Abstract)

POSTER 65, Wei Shao
New Bioinformatic Algorithm to Detect Recent HIV-1 Infection (Abstract)

POSTER 66, David Sacks
Development of a Real-Time PCR Incorporating High Resolution
Melting Analysis to Detect Resistance-Related Single Nucleotide
Polymorphisms in the HIV-1 Reverse Transcriptase Gene (Abstract)

POSTER 67, Maame Sampah
Analysis of Dose Response Curves in Drug Resistant HIV (Abstract)

POSTER 68, Kirsten White
HIV-1 RT Mutant Q151L Has a Unique NRTI Susceptibility Profile
and Severely Reduced Fitness That Can Be Partially Compensated
by S68N and L74I (Abstract)

POSTER 69, Jean Ndjomou
Viral DNA Is Detected in Multiple Tissues after Sustained Suppression
of Plasma Viremia in the RT-SHIV_mne Macaque Model (Abstract)

POSTER 70, Joshua Waters
Integrase Genotypic Diversity in HIV-1 Infected Patients Naïve to
Integrase Inhibitor Therapy (Abstract)

POSTER 71, Derrick Goodman
Sequence Variations Observed in Viral LTR Ends in Plasma HIV-1
from Patients Do Not Affect Susceptibility to Integrase Inhibitors in Vitro (Abstract)

POSTER 72, Yutaka Takebe
Unusual Evolutionary Characteristics of CRF15_01B: Evidence for
Preferred Configuration of HIV-1 Recombination (Abstract)